Helminthiasis Clinical Trial
Official title:
Assessment of Drug Efficacy of Albendazole Bought on Local Market Against Soil-transmitted Helminth Infections in School Children in Jimma, Ethiopia
Verified date | December 2022 |
Source | University Ghent |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Infections with soil-transmitted helminthes (STH) occur throughout the developing world and remain a major public health problem in the poorest communities. Preventive chemotherapy (PC) programs in which single-dose albendazole 400 mg or single-dose mebendazole 500 mg - the drugs of choice for STH - are administered at the population level, is the main strategy for STH control. To ensure quality, these drugs are being widely donated by GlaxoSmithKline (GSK) (albendazole (ALB), Zentel) and Johnson & Johnson (mebendazole (MEB), Vermox). In addition to this, there are a wide variety of ALB and MEB tablets available on the local market. Although little is known about the quality of anthelmintics sold for human use, several publications have reported variability in the quality of generic anthelmintics used in veterinary medicine. The main objective of the present study is to compare the efficacy of two ALB brands bought on the local market, including OVIS (Korea, DAEHWA pharmaceutical) and BENDEX (India, Cipla)
Status | Completed |
Enrollment | 679 |
Est. completion date | February 2015 |
Est. primary completion date | April 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 5 Years to 18 Years |
Eligibility | Inclusion Criteria: 1. Age: 5-18 years old. 2. Sex: males and females. 3. Signed of written informed consent sheet by parents/or guardians, and those who volunteered to comply with study procedures (stool submission, drug treatment). 4. Females: was not pregnant (as verbally assessed by clinician upon enrolled to treatment). Exclusion Criteria: 1. Had vomit within 4 hours after drug administration. 2. Had diarrhea at time of the first sampling. 3. Subjects who were unable to provide a stool sample at follow-up, 4. Subjects who experienced a severe concurrent medical condition 5. Subjects with known history of allergic reaction to ALB. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University Ghent |
Bethony J, Brooker S, Albonico M, Geiger SM, Loukas A, Diemert D, Hotez PJ. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet. 2006 May 6;367(9521):1521-32. doi: 10.1016/S0140-6736(06)68653-4. — View Citation
Bundy DA, Hall A, Medley GF, Savioli L. Evaluating measures to control intestinal parasitic infections. World Health Stat Q. 1992;45(2-3):168-79. — View Citation
Crompton DW, Nesheim MC. Nutritional impact of intestinal helminthiasis during the human life cycle. Annu Rev Nutr. 2002;22:35-59. doi: 10.1146/annurev.nutr.22.120501.134539. Epub 2002 Jan 4. — View Citation
Curtale F, Pokhrel RP, Tilden RL, Higashi G. Intestinal helminths and xerophthalmia in Nepal. A case-control study. J Trop Pediatr. 1995 Dec;41(6):334-7. doi: 10.1093/tropej/41.6.334. — View Citation
De Clercq D, Sacko M, Behnke J, Gilbert F, Dorny P, Vercruysse J. Failure of mebendazole in treatment of human hookworm infections in the southern region of Mali. Am J Trop Med Hyg. 1997 Jul;57(1):25-30. doi: 10.4269/ajtmh.1997.57.25. — View Citation
Monteiro AM, Wanyangu SW, Kariuki DP, Bain R, Jackson F, McKellar QA. Pharmaceutical quality of anthelmintics sold in Kenya. Vet Rec. 1998 Apr 11;142(15):396-8. doi: 10.1136/vr.142.15.396. — View Citation
Nokes C, Bundy DA. Does helminth infection affect mental processing and educational achievement? Parasitol Today. 1994 Jan;10(1):14-8. doi: 10.1016/0169-4758(94)90348-4. — View Citation
Stephenson LS, Latham MC, Adams EJ, Kinoti SN, Pertet A. Physical fitness, growth and appetite of Kenyan school boys with hookworm, Trichuris trichiura and Ascaris lumbricoides infections are improved four months after a single dose of albendazole. J Nutr. 1993 Jun;123(6):1036-46. doi: 10.1093/jn/123.6.1036. — View Citation
Stoltzfus RJ, Albonico M, Chwaya HM, Savioli L, Tielsch J, Schulze K, Yip R. Hemoquant determination of hookworm-related blood loss and its role in iron deficiency in African children. Am J Trop Med Hyg. 1996 Oct;55(4):399-404. doi: 10.4269/ajtmh.1996.55.399. — View Citation
Vercruysse J, Behnke JM, Albonico M, Ame SM, Angebault C, Bethony JM, Engels D, Guillard B, Nguyen TV, Kang G, Kattula D, Kotze AC, McCarthy JS, Mekonnen Z, Montresor A, Periago MV, Sumo L, Tchuente LA, Dang TC, Zeynudin A, Levecke B. Assessment of the anthelmintic efficacy of albendazole in school children in seven countries where soil-transmitted helminths are endemic. PLoS Negl Trop Dis. 2011 Mar 29;5(3):e948. doi: 10.1371/journal.pntd.0000948. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Egg reduction rate | 14 days after administration of the drugs |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04041453 -
Albendazole Plus High Dose Ivermectin for Trichuriasis in Pediatric Patients
|
Phase 2 | |
Active, not recruiting |
NCT03014167 -
Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths (STH)
|
Phase 3 | |
Completed |
NCT02385058 -
Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican Population
|
Phase 4 | |
Withdrawn |
NCT02636803 -
Study of the Efficacy of Oxfendazole Compared to Albendazole in the Treatment of Trichuris Trichiura Infection in Adults
|
Phase 2 | |
Completed |
NCT02725255 -
Design and Clinical Evaluation of a School Meal With Deworming Properties
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT04227834 -
Soil-transmitted Helminth Reinfection Rates After Single and Repeated School Hygiene Education
|
N/A | |
Completed |
NCT03173742 -
Bioavailability and Safety of Two Oral Fixed Dose Preparations Containing 18 mg Ivermectin (IVM 18 MG TABLETS, LICONSA S.A., Spain) Versus Reference Dosing (Weight Based) Containing 6 mg Ivermectin (REVECTINA®, Abbott Laboratórios do Brasil Ltda, Brazil)
|
Phase 1 | |
Completed |
NCT02397772 -
Impact of Alternative Treatment Strategies and Delivery Systems for Soil-transmitted Helminths in Kenya
|
Phase 4 | |
Completed |
NCT00130910 -
Treatment of Helminth co-Infection: Short-Term Effects on HIV-1 Progression Markers and Immune Activation
|
N/A | |
Completed |
NCT00004996 -
Comparison of Immune Response in Normal Volunteers and Patients With Helminth Infections
|
||
Recruiting |
NCT00001230 -
Host Response to Infection and Treatment in Filarial Diseases
|
||
Completed |
NCT04041427 -
Urine Albendazole Levels for Coverage Assessment
|
N/A | |
Completed |
NCT02396407 -
Spillover Effects of Water, Sanitation, and Hygiene Interventions on Child Health
|
N/A | |
Terminated |
NCT01271049 -
An Evaluation of a Novel Food Product in Adults Residing in an Area Endemic for Helminths
|
N/A | |
Terminated |
NCT00817713 -
Can Presumptive Anthelminthic Treatment Delay the Progression of HIV in ART-naïve Patients in Rural Africa?
|
N/A | |
Completed |
NCT02362932 -
The Effect of an Urban Sanitation Intervention on Child Health
|
N/A | |
Completed |
NCT00507221 -
Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression
|
N/A | |
Completed |
NCT00469495 -
Antihelminthic Therapy Combined With Antimony in the Treatment of Cutaneous Leishmaniasis
|
N/A | |
Recruiting |
NCT01308268 -
Management of Soil-transmitted Helminthiasis and Strongyloidiasis
|
N/A | |
Recruiting |
NCT01459146 -
Artemisinin-based Combination Therapy-Intermittent Preventive Treatment (ACT-IPT) Trial Among Schoolchildren in Kassena-Nankana, Ghana
|
Phase 4 |